Skip to main content

Peer Review reports

From: Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population

Original Submission
20 Oct 2019 Submitted Original manuscript
21 Nov 2019 Reviewed Reviewer Report - Mohammed Najeeb Al-Hallak
22 Nov 2019 Reviewed Reviewer Report - Rinat Bernstein
21 Dec 2019 Author responded Author comments - fan Yang
27 Jan 2020 Author responded Author comments - fan Yang
Resubmission - Version 2
21 Dec 2019 Submitted Manuscript version 2
1 Feb 2020 Author responded Author comments - fan Yang
Resubmission - Version 3
1 Feb 2020 Submitted Manuscript version 3
11 Feb 2020 Author responded Author comments - fan Yang
Resubmission - Version 4
11 Feb 2020 Submitted Manuscript version 4
Publishing
17 Feb 2020 Editorially accepted
29 Mar 2020 Article published 10.1186/s12885-020-6639-4

You can find further information about peer review here.

Back to article page